Natalia Wilkosz

Natalia Wilkosz

Auto-generated profile, based on publicly available information

Natalia Wilkosz

Faculty of Physics, Astronomy and Applied Computer Science, Department of Physics of Nanostructures and Nanotechnology Jagiellonian University Krakow Poland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2018 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
NWNatalia Wilkosz
Natalia Wilkosz
GŁGrzegorz Łazarski
Grzegorz Łazarski
LKLubomir Kovacik
Lubomir Kovacik
PGPatrycja Gargas
Patrycja Gargas
MNMaria Nowakowska
Maria Nowakowska
MKMariusz Kepczynski
Mariusz Kepczynski

18 December 2023 in The Analyst
Verified
Journal Article
Open access
PDF file
TSTetiana Stepanenko
Tetiana Stepanenko
KSKamila Sofińska
Kamila Sofińska
NWNatalia Wilkosz
Natalia Wilkosz
JDJakub Dybas
Jakub Dybas
EWEwelina Wiercigroch
Ewelina Wiercigroch
KMKatarzyna M. Marzec
Katarzyna M. Marzec
Chemical characterization of extracellular microvesicles (REVs) and isolated membranes derived from red blood cells (RBCs) was carried out in a non-destructive and label-free manner with surface-enhanced Raman spectroscopy (SERS) and tip-enhanced Raman spectroscopy (TERS).

3 December 2018 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
NANeha Awasthi
Neha Awasthi
WKWojciech Kopec
Wojciech Kopec
NWNatalia Wilkosz
Natalia Wilkosz
DJDorota Jamróz
Dorota Jamróz
JHJochen S. Hub
Jochen S. Hub
MKMariusz Kepczynski
Mariusz Kepczynski

19 July 2017 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
NWNatalia Wilkosz
Natalia Wilkosz
DJDorota Jamróz
Dorota Jamróz
WKWojciech Kopeć
Wojciech Kopeć
KNKeita Nakai
Keita Nakai
Shin-ichi YusaShin-ichi Yusa
Shin-ichi Yusa
MKMariusz Kepczynski
Mariusz Kepczynski

1 March 2017 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
NWNatalia Wilkosz
Natalia Wilkosz
SRSami Rissanen
Sami Rissanen
MCMałgorzata Cyza
Małgorzata Cyza
RSRenata Szybka
Renata Szybka
MNMaria Nowakowska
Maria Nowakowska
MKMariusz Kepczynski
Mariusz Kepczynski

23 February 2024 in Acta Physiologica
Verified
Journal Article
Open access
KWKamila Wojnar-Lasoń
Kamila Wojnar-Lasoń
UTUrszula Tyrankiewicz
Urszula Tyrankiewicz
AKAgnieszka Kij
Agnieszka Kij
AKAnna Kurpinska
Anna Kurpinska
PKPatrycja Kaczara
Patrycja Kaczara
SCStefan Chlopicki
Stefan Chlopicki
Aim: Chronic heart failure (CHF) is often linked to liver malfunction and systemic endothelial dysfunction. However, whether cardio‐hepatic interactions in heart failure involve dysfunction of liver sinusoidal endothelial cells (LSECs) is not known. Here we characterize LSECs phenotype in early and end stages of chronic heart failure in a murine model.Methods: Right ventricle (RV) function, features of congestive hepatopathy, and the phenotype of primary LSECs were characterized in Tgαq*44 mice, with cardiomyocyte‐specific overexpression of the Gαq protein, at the age of 4‐ and 12‐month representative for early and end‐stage phases of CHF, respectively.Results: 4‐ and 12‐month‐old Tgαq*44 mice displayed progressive impairment of RV function and alterations in hepatic blood flow velocity resulting in hepatic congestion with elevated GGT and bilirubin plasma levels and decreased albumin concentration without gross liver pathology. LSECs isolated from 4‐ and 12‐month‐old Tgαq*44 mice displayed significant loss of fenestrae with impaired functional response to cytochalasin B, significant changes in proteome related to cytoskeleton remodeling, and altered vasoprotective function. However, LSECs barrier function and bioenergetics were largely preserved. In 4‐ and 12‐month‐old Tgαq*44 mice, LSECs defenestration was associated with prolonged postprandial hypertriglyceridemia and in 12‐month‐old Tgαq*44 mice with proteomic changes of hepatocytes indicative of altered lipid metabolism.Conclusion: Tgαq*44 mice displayed right‐sided HF and altered hepatic blood flow leading to LSECs dysfunction involving defenestration, shift in eicosanoid profile, and proteomic changes. LSECs dysfunction appears as an early and persistent event in CHF, preceding congestive hepatopathy and contributing to alterations in lipoprotein transport and CHF pathophysiology.